High RMI1 expression is associated with cancer cell progression and poor prognosis in prostate cancer
Oncology Reports · 2026
DOI: 10.3892/or.2026.9060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Reports, 2026. Verfasst von Pengliang Shen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Biomarkers, Tumor, Nuclear Proteins, Carrier Proteins. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China.
- First Clinical Medical College, Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China.
Zitieren
APA
Shen, P., Wang, X., Yan, X., Du, H., Wu, B., & Cao, X. (2026). High RMI1 expression is associated with cancer cell progression and poor prognosis in prostate cancer. Oncology Reports. https://doi.org/10.3892/or.2026.9060
Vancouver
Shen P, Wang X, Yan X, Du H, Wu B, Cao X. High RMI1 expression is associated with cancer cell progression and poor prognosis in prostate cancer. Oncology Reports. 2026. doi:10.3892/or.2026.9060
BibTeX
@article{Shen2026,
author = {Shen, Pengliang and Wang, Xiaosong and Yan, Xiaoting and Du, Hongyang and Wu, Bo and Cao, Xiaoming},
title = {High RMI1 expression is associated with cancer cell progression and poor prognosis in prostate cancer},
journal = {Oncology Reports},
year = {2026},
doi = {10.3892/or.2026.9060}
}
EUVIMED